Pfizer Stock News

Pfizer's pipeline already includes two obesity drugs. However, doubts about Pfizer's lead obesity program could make buying Viking a smart move.

Following the label expansion, Pfizer's (PFE) 20-valent pneumococcal conjugate vaccine is authorized for use in individuals aged six weeks and older.

Undervalued healthcare stocks are primed for a comeback this year, proving themselves as lucrative investments amidst a revitalized market. With a significant uptick in performance, the S&P 500 Health

Stock investors who want to receive $2,000 per month in dividend payments first have to do some quick math. A dividend portfolio with stocks valued at $480,000 yielding 5% overall would produce $24,00

Edge computing tech specialist Fastly is capitalizing on an underserved aspect of the cloud computing market. StoneCo is arguably one of the best names in the small-business payment-acceptance space.

In the closing of the recent trading day, Pfizer (PFE) stood at $28.22, denoting a +0.75% change from the preceding trading day.

Pfizer (PFE) plans to seek approval for the eighth indication for Adcetris based on data from the ECHELON-3 study.

While searching for investment, there is a search for the holy grail. These are the stocks that have the potential to multiply returns exponentially.

The Investment Committee shares their top stocks to watch for the second half.

The company's core business is leasing space on its wireless towers, primarily to wireless carriers, government agencies, and broadband data providers.

Pfizer's cancer drug Adcetris extended survival in patients with a common form of lymphoma in a late-stage trial, the company announced Tuesday, supporting Pfizer's efforts to expand into cancer treat

Pfizer's Q4 FY2023 financials show a significant downturn in consolidated revenues, with a 93% decline in profit for the full year. Sales of Comirnaty and Paxlovid, Pfizer's COVID-related drugs, fell

Pfizer said on Tuesday a combination treatment using its drug, Adcetris, met its main goal of overall survival when tested in patients with a type of blood cancer.

Are you ready for retirement? Planning for retirement can be overwhelming, that's why it could be a good idea to speak to a fiduciary financial advisor about your goals today.

Pfizer is pushing to be more involved in cancer drugs after a turbulent year marked by the rapid decline of its COVID business. During a four-hour investor event last week, Pfizer pushed its initative